Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver Biopsy

Immune checkpoint inhibitor (ICI)-induced liver injury (LI) is a common adverse event, but the clinical characteristics based on the classification of hepatocellular injury and cholestatic types are not fully evaluated. This study aims to analyze risk factors and histological findings in relation to...

Full description

Bibliographic Details

Published in:	Diagnostics
Main Authors:	Miki Kawano, Yoshihiko Yano, Atsushi Yamamoto, Eiichiro Yasutomi, Yuta Inoue, Jun Kitadai, Ryutaro Yoshida, Takanori Matsuura, Yuuki Shiomi, Yoshihide Ueda, Yuzo Kodama
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Subjects:	immune checkpoint inhibitor liver injury DILI histology
Online Access:	https://www.mdpi.com/2075-4418/14/8/815